PUBLICATION 研究成果(論文・学会発表)

発表論文(英文)

2019年

(2) Hiroyuki Yamada, Kent Doi, Tatsuo Tsukamoto, Hideyasu Kiyomoto, Kazuto Yamashita, Motoko Yanagita, Yoshio Terada, Kiyoshi Mori.
“Low-dose atrial atriuretic peptide for prevention or treatment of acute kidney injury: a systematic review and meta-analysis”
Crit Care. 2019;23(1):41. (Accepted: 22 January 2019)

(1) Shusuke Hiragi, Rei Goto, Yukari Tanaka, Yoko Matsuyama, Atsuro Sawada, Kaoru Sakai, Hitomi Miyata, Hiroshi Tamura, Motoko Yanagita, Tomohiro Kuroda, Osamu Ogawa, Takashi Kobayashi.
“Estimating the Net Utility Gains Among Donors and Recipients of Adult Living Donor Kidney Transplant”
Transplant Proc. 2019 Apr;51(3):676-683. (Accepted: 17 January 2019)

2018年

(11) Erina Ono, Eiichiro Uchino, Keita P. Mori, Hideki Yokoi, Naohiro Toda, Kenichi Koga, Masato Kasahara, Takeshi Matsubara, Motoko Yanagita.
“Peritonitis due to Mycobacterium abscessus in peritoneal dialysis patients: case presentation and mini-review”
Ren Replace Ther. 2018;4:52. (Accepted: 19 November 2018)

(10) Jin Nakamura, Yuki Sato, Yuichiro Kitai, Shuichi Wajima, Shinya Yamamoto, Akiko Oguchi, Ryo Yamada, Keiichi Kaneko, Makiko Kondo, Eiichiro Uchino, Junichi Tsuchida, Keita Hirano, Kumar Sharma, Kenji Kohno, Motoko Yanagita.
“Myofibroblasts acquire retinoic acid–producing ability during fibroblast-to-myofibroblast transition following kidney injury”
Kidney Int. in press. (Accepted: 4 October 2018)

(9) Yuki Sato, Motoko Yanagita.
“Immune cells and inflammation in AKI to CKD progression”
Am J Physiol Renal Physiol. 2018;315(6):F1501–F1512. (Accepted: 26 August 2018)

(8) Naohiro Toda, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“CTGF in kidney fibrosis and glomerulonephritis”
Inflamm Regen. 2018;38:14. (Accepted 8 May 2018)

(7) Naoya Toriu, Junichi Hoshino, Saeko Kobori, Sun Watanabe, Masahiko Oguro, Yoichi Oshima, Rikako Hiramatsu, Hiroki Mizuno, Daisuke Ikuma, Akinari Sekine, Noriko Hayami, Keiichi Sumida, Masayuki
Yamanouchi, Eiko Hasegawa, Naoki Sawa, Kenmei Takaichi, Motoko Yanagita, Takuya Fujimaru, Eisei Hohara, Shinichi Uchida, Yoshifumi Ubara.
“Transcatheter Arterial Embolization Therapy for Huge Renal Cysts: Two Case Reports”
Case Rep Nephrol Dial. 2018;8(1):82–89. (Accepted: 9 Apr 2018)

(6) Naoya Toriu, Hiroki Mizuno, Naoki Sawa, Keiichi Sumida, Tatsuya Suwabe, Noriko Hayami, Akinari Sekine, Masayuki Yamanouchi, Junichi Hoshino, Kenmei Takaichi, Motoko Yanagita, Takuya Fujimaru, Takayasu Mori, Eisei Sohara, Shinichi Uchida, Yoshifumi Ubara.
“Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter”
Case Rep Oncol. 2018;11(2):258–267. (Accepted: 22 Mar 2018)

(5) Rin Asao, Takuto Seki, Miyuki Takagi, Hiroyuki Yamada, Fumiko Kodama, Yoshiko Hosoe-Nagai, Eriko Tanaka, Juan Alejandro Oliva Trejo, Kanae Yamamoto-Nonaka, Yu Sasaki, Teruo Hidaka, Takashi Ueno, Motoko Yanagita, Yusuke Suzuki, Yasuhiko Tomino, Katsuhiko Asanuma.
“Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis”
Sci Rep. 2018;8(1):5061. (Accepted: Mar 6, 2018)

(4) Hiroyuki Arai, Naohiro Toda, Ryo Kamimatsuse, Keisuke Nishioka, Shuichiro Endo, Shinichi Akiyama, Shoichi Maruyama, Takeshi
Matsubara, Hideki Yokoi, Motoko Yanagita.
“A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis”
Intern Med. 2018 Intern Med. 2018;57(19):2873–2877. (Accepted: Feb 18, 2018)

(3) Shusuke Hiragi, Hiroyuki Yamada, Tatsuo Tsukamoto, Kazuki Yoshida, Naoya Kondo, Takeshi Matsubara, Motoko Yanagita, Hiroshi Tamura, Tomohiro Kuroda.
“Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study”
Clin Epidemiol. 2018;10:265–276. (Accepted: Jan 24, 2018)

(2) Taku Iguchi, Koji Takaori, Akiko Mii, Yuki Sato, Yasunori Suzuki,
Hajime Yoshifuji, Hiroshi Seno, Osamu Ogawa, Koichi Omori, Kazuhisa Bessho, Satoru Kondo, Tomokazu Yoshizaki, Hitoshi Nakashima, Takao Saito, Tsuneyo Mimori, Hironori Haga, Mitsuhiro Kawano, Motoko Yanagita.
“Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease”
Mod Pathol. 2018;31(6):890–899. (Accepted: Jan 17, 2018)

(1) Eiichiro Uchino, Daisuke Takada, Haruta Mogami, Takeshi Matsubara, Tatsuo Tsukamoto, Motoko Yanagita.
“Membranous nephropathy associated with pregnancy: an anti-phospholipase A2 receptor antibody-positive case report”
CEN Case Rep. 2018;7(1):101–106. (Accepted: Jan 10, 2018)

2017年

(12) Naoya Toriu, Masayuki Yamanouchi, Rikako Hiramatsu, Noriko Hayami, Junichi Hoshino, Akinari Sekine, Masahiro Kawada, Eiko Hasegawa, Tatsuya Suwabe, Keiichi Sumida, Toshiharu Ueno, Naoki Sawa, Kenichi Ohashi, Takeshi Fujii, Kenmei Takaichi, Motoko Yanagita, Tetsuro Kobayasi, Yoshifumi Ubara.
“Preservation of renal function by intensive glycemic control”
Endocrinol Diabetes Metab Case Rep. 2018; 2018:17–0136. (Accepted: Dec 6, 2017)

(11) Naoya Toriu, Naoki Sawa, Masahiko Oguro, Hiroki Mizuno, Yoichi Oshima, Eiko Hasegawa, Keiichi Sumida, Tatsuya Suwabe, Masahiro Kawada, Toshiharu Ueno, Noriko Hayami, Akinari Sekine, Rikako Hiramatsu, Masayuki Yamanouchi, Junichi Hoshino, Kenmei Takaichi, Kenichi Ohashi, Takeshi Fujii, Motoko Yanagita, Yoshifumi Ubara.
“Renal-limited cryoglobulinemic vasculitis: Two case reports”
Interm Med. 2018;57(13):1879–1886. (Accepted: Dec 5, 2017)

(10) Akira Ishii, Goro Katsuura, Hirotaka Imamaki, Hiroyuki Kimura, Keita P.Mori, Takashige Kuwabara, Masato Kasahara, Hideki Yokoi, Kousaku Ohinata, Tomoko Kawanishi, Junichi Tsuchida, Yuji Nakamoto, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama, Kiyoshi Mori.
“Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice”
Sci Rep. 2017;7(1):15501. (Accepted: Nov 1, 2017)

(9) Naohiro Toda, Kiyoshi Mori, Masato Kasahara, Kenichi Koga, Akira Ishii, Keita P.Mori, Keisuke Osaki, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation”
Nephrol Dial Transplant. 2018;33(6):943–953. (Accepted: October 9, 2017)

(8) Daisuke Takada, Tatsuo Tsukamoto, Miho Fuse, Shinpei Kada, Motoko Yanagita.
“The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: A case report”
BMC Nephrol. 2017;18(1):315. (Accepted: Sep 28, 2017)

(7) Hiroyuki Yamada, Munehiro Ito, Tatsuo Tsukamoto, Motoko Yanagita.
“Skin rash in a patient with antineutrophil cytoplasmic antibody vasculitis”
Kidney Int. 2017;92(1):269. (Published: June 21, 2017)

(6) Yuki Sato, Motoko Yanagita.
“Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation”
Inflamm Regen. 2017;37:17. (Accepted: May 9, 2017)

(5) Naritoshi Shirata, Kan-ichiro Ihara, Kanae Yamamoto-Nonaka, Takuto Seki, Shin-ichi Makino, Juan Alejandro Oliva Trejo, Takafumi Miyake, Hiroyuki Yamada, Kirk Campbell, Takahiko Nakagawa, Kiyoshi Mori, Motoko Yanagita, Peter Mundel, Katsuhiko Nishimori, Katsuhiko Asanuma.
“Glomerulosclerosis Induced by deficiency of membrane-associated guanylate kinase inverted 2 in kidney podocytes”
J Am Soc Nephrol. 2017;28(9):2654–2669. (Accepted: April 3, 2017)

(4) Rio Noto, Nozomu Kamiura, Yuichiro Ono, Sumie Tabata, Shigeo Hara, Hideki Yokoi, Akihiro Yoshimoto, Motoko Yanagita.
“Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report”
BMC Nephrology 2017;18(1):127. (Accepted: Mar 23, 2017)

(3) Yukiko Kato, Kiyoshi Mori, Masato
Kasahara, Keisuke Osaki, Akira Ishii, Keita P. Mori, Naohiro Toda, Shoko Ohno, Takashige Kuwabara, Takeshi Tokudome, Ichiro Kishimoto, Moin A. Saleem, Matsusaka, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition”
Sci Rep. 2017;7:46624. (Accepted: Mar 22, 2017)

(2) Noriaki Sato, Hideki Yokoi, Hirotaka Imamaki, Eiichiro Uchino, Kaoru Sakai, Takeshi Matsubara, Tatsuo Tsukamoto, Sachiko Minamiguchi, Motoko Yanagita.
“Renal-limited vasculitis with elevated levels of multiple antibodies”
CEN Case Reports 2017;6(1):79–84. (Accepted: Jan 18, 2017)

(1) Naohiro Toda, Kiyoshi Mori, Masato Kasahara, Akira Ishii, Kenichi Koga, Keita P. Mori, Yukiko Kato, Takashige Kuwabara, Katsutoshi Kojima, Diasuke Taura, Masakatsu Sone, Taiji Matsusaka, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“Crucial role of mesangial cell-derived connective tissue growth factor in a mouse model of anti-glomerular basement membrane glomerulonephritis”
Sci Rep. 2017;7:42114. (Accepted: Jan 6, 2017)

2016年

(14) Eiichiro Uchino, Naoya Kondo, Takeshi Matsubara, Motoko Yanagita.
“Automated electronic alert systems for acute kidney injury: Current status and future perspectives”
Contrib Nephrol. 2017;189:124–129. (Accepted: December 12, 2016)

(13) Maki Shinzawa, Shiro Tanaka, Hironobu Tokumasu, Daisuke Takada, Tatsuo Tsukamoto, Motoko Yanagita, Koji Kawakami.
“Maternal smoking during pregnancy, household smoking after the child’s birth, and childhood proteinuria at age 3 years”
Clin J Am Soc Nephrol. 2017;12(2):253–260. (Accepted: Oct 24, 2016)

(12) Hiroyuki Yamada, Tatsuo Tsukamoto, Hiromichi Narumiya, Kazumasa Oda, Satoshi Higaki, Ryoji Iizuka, Motoko Yanagita, Masako Deguchi.
“Initial central venous pressure could be a prognostic marker for hemodynamic improvement of polymyxin-B direct hemoperfusion for septic shock patients: a retrospective cohort study”
J Intensive Care. 2016;4:64. (Accepted Sep 15, 2016)

(11) Mitchell H Rosner, Amaka Edeani, Motoko Yanagita, Ilya G. Glezerman, Nelson Leung.
“Paraprotein-related kidney disease: Diagnosing and treating monoclonal gammopathy of renal significance”
Clin J Am Soc Nephrol. 2016;11(12):2280–2287. (Published: August 15, 2016)

(10) Takaori K, Yanagita M.
“Insights into the Mechanisms of the acute kidney injury-to-chronic kidney disease continuum”
Nephron. 2016;134:172–176. (Accepted: Jun 26, 2016)

(9) Yuki Sato, Akiko Mii, Yoko Hamazaki, Harumi Fujita, Hirosuke Nakata, Kyoko Masuda, Shingo Nishiyama, Shinsuke Shibuya, Hironori Haga, Osamu Ogawa, Akira Shimizu, Shuh Narumiya, Tsuneyasu Kaisho, Makoto Arita, Masashi Yanagisawa, Masayuki Miyasaka, Kumar Sharma, Nagahiro Minato, Hiroshi Kawamoto, Motoko Yanagita.
“Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney”
JCI Insight. 2016;1(11):e87680. (Accepted: Jun 13, 2016)

(8) Keita P. Mori, Hideki Yokoi, Masato Kasahara, Hirotaka Imamaki, Akira Ishii, Takashige Kuwabara,
Kenichi Koga, Yukiko Kato, Naohiro Toda, Shoko Ohno, Koichiro Kuwahara, Tomomi Endo, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama, Kiyoshi Mori.
“Increase of total nephron albumin filtration and reabsorption in diabetic Nephropathy”
J Am Soc Nephrol. 2017;28:278–289. (Accepted: May 28, 2016)

(7) Shoko Ohno, Hideki Yokoi, Kiyoshi Mori, Masato Kasahara, Koichiro Kuwahara, Junji Fujikura, Masaki Naito, Takashige Kuwabara, Hirotaka Imamaki, Akira Ishii, Moin A. Saleem, Tomohiro Numeta, Yasuo Mori, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama.
“Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure”
Sci Rep. 2016;6:27192. (Accepted May 16, 2016)

(6) Shingo Fukuma, Sayaka Shimizu, Kakuya Niihata, Ken-ei Sada, Motoko Yanagita, Tsuguru Hatta, Masaomi Nangaku, Ritsuko Katafuchi, Yoshiro Fujita, Junji Koizumi, Shunzo Koizumi, Kenjiro Kimura, Shunichi Fukuhara, Yugo Shibagaki.
“Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method”
Clin Exp Nephrol.
2017;21:247–256.
(Accepted: Apr 22, 2016)

(5) Hideki Yokoi, Motoko Yanagita.
“Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease”
Kidney Int. 2016;89:740–742. (Published: Mar 16, 2016)

(4) Hitoshi Nakashima, Mitsuhiro Kawano, Takako Saeki, Yoshifumi Ubara, Satoshi Hisano, Michio Nagata, Yoh Zen, Motoko Yanagita, Yutaka Yamaguchi, Shinichi Nishi, Takao Saito.
“Estimation of the number of histological Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings”
Clin Exp Nephrol. 2017;21:97–103. (Accepted Mar 10, 2016)

(3) Takeshi Yamamoto, Yoshitsugu Takabatake, Tomonori Kimura, Atsushi Takahashi, Tomoko Namba, Jun Matsuda, Jun-ya Kaimori, Isao Matsui, Harumi Kitamura, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Yoshitaka Isaka, Hiromi Rakugi.
“Time-dependent dysregulation of autophagy: Implications in aging and mitochondrial homeostasis in the kidney proximal tubule”
Autophagy. 2016;12:801–813. (Accepted: Feb 24, 2016)

(2) Takeshi Matsumoto, Kimihiko Murase, Ryo Tachikawa, Takuma Minami, Satoshi Hamada, Kiminobu Tanizawa, Morito Inouchi, Tomohiro Handa, Toru Oga, Motoko Yanagita, Michiaki Mishima, Kazuo Chin.
“Microalbuminuria in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome”
Ann Am Thorac Soc. 2016;13:917–925. (Accepted: Jan 24, 2016)

(1) Tatsuo Tsukamoto, Takayuki Matsubara, Yuka Akashi, Morihiro Kondo, Motoko Yanagita.
“Annual iron loss associated with hemodialysis”
Am J Nephrol. 2016;43:32–38. (Accepted: Jan 24, 2016)

2015年

(13) Takeshi Matsubara T, Osamu Ogawa, Motoko Yanagita.
“Physical finding of nutcracker phenomenon”
Kidney Int. 2013;83(2):335. (Published: Dec 16, 2015)

(12) Hideki Yokoi and
Motoko Yanagita.
“Decrease of muscle volume in chronic kidney disease: the role of mitochondria in skeletal muscle”
Kidney Int. 2014; 85(6):1258–1260. (Published: Dec 16, 2015)

(11) Shota Ozawa, Shuko Ueda, Hiromi Imamura, Kiyoshi Mori, Katsuhiko Asanuma, Motoko Yanagita, Takahiko Nakagawa.
“Glycolysis, but not Mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes”
Sci Rep. 2015;5:18575. (Accepted: Nov 23, 2015)

(10) Koji Takaori, Jin Nakamura, Shinya Yamamoto, Hirosuke Nakata, Yuki Sato, Masayuki Takase, Masaaki Nameta, Tadashi Yamamoto, Aris N. Economides, Kenji Kohno, Hironori Haga, Kumar Sharma, Motoko Yanagita.
“Severity and frequency of proximal tubule injury determines renal prognosis”
J Am Soc Nephrol. 2016;27(8):2393–2406. (Accepted: Nov 15, 2015)

(9) Shunsaku Nakagawa, Kumiko Nishihara, Hitomi Miyata, Haruka Shinke, Eri Tomita, Moto Kajiwara, Takeshi Matsubara, Noriyuki Iehara, Yoshinobu Igarashi, Hiroshi Yamada, Atsushi Fukatsu, Motoko Yanagita, Kazuo Matsubara, Satohiro Masuda.
“Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic Kidney disease”
PLoS One. 2015;10:e0136994. (Accepted: Aug 11, 2015)

(8) Hirotaka Imamaki, Akira Ishii, Hideki Yokoi, Masato Kasahara, Takashige Kuwabara, Keita P. Mori, Yukiko Kato, Takashi Kuwahara, Masugi Satoh, Kimihiko Nakatani, Yoshihiko Saito, Naohisa Tomosugi, Akira Sugawara, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Kiyoshi Mori.
“Low serum neutrophil gelatinase-associated lipocalin level as a marker of malnutrition in maintenance hemodialysis patients”
PLoS One. 2015;10:e0132539. (Accepted: Jun 17, 2015)

(7) Shuko Ueda, Shota Ozawa, Kiyoshi Mori, Katsuhiko Asanuma, Motoko Yanagita, Shunya Uchida, Takahiko Nakagawa.
“ENOS deficiency causes podocyte injury with mitochondrial abnormality”
Free Radic Biol Med. 2015;87:181–192. (Accepted: Jun 8, 2015)

(6) Kenichi Koga, Hideki Yokoi, Kiyoshi Mori, Masato Kasahara, Takashige Kuwabara, Hirotaka Imamaki, Akira Ishii, Keita P. Mori, Yukiko Kato, Shoko Ohno, Naohiro Toda, Moin A. Saleem, Akira Sugawara, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama.
“MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy”
Diabetologia. 2015;58(9):2169–2180. (Accepted: Apr 29, 2015)

(5) Takeshi Matsubara, Makoto Araki, Hideharu Abe, Otoya Ueda, Kou-ichi Jishage, Akira Mima, Chisato Goto, Tatsuya Tominaga, Masahiko Kinosaki, Seiji Kishi, Kojiro Nagai, Noriyuki Iehara, Naoshi Fukushima, Toru Kita, Hidenori Arai and Toshio Doi.
“Bone morphogenetic protein 4 and Smad1 mediate extracellular matrix production in the development of diabetic nephropathy”
Diabetes. 2015;64(8):2978–2990. (Accepted: Apr 12, 2015)

(4) Matthias Mack, Motoko Yanagita.
“Origin of myofibroblasts and cellular events triggering fibrosis”
Kidney Int. 2015;87:297–307. (Accepted: Apr 10, 2014)

(3) Shigeo Hara, Shunsuke Goto, Nozomu Kamiura, Akihiro Yoshimoto, Takayuki Naito, Naoko Imagawa, Yukihiro Imai, Motoko Yanagita, Shinichi Nishi, Tomoo Itoh.
“Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype”
Virchows Archiv. 2015;467(1):87–94. (Accepted: Mar 9, 2015)

(2) Yuichiro Kitai, Takeshi Matsubara, Motoko Yanagita.
“Onco-nephrology: current concepts and future perspectives”
Jpn J Clin Oncol. 2015; 45(7):617–628. (Accepted: Feb 17, 2015)

(1) Tomomi Endo, Jin Nakamura, Yuki Sato, Misako Asada, Ryo Yamada, Masayuki Takase, Koji Takaori, Akiko Oguchi, Taku Iguchi, Atsuko Y. Higashi, Tetsuya Ohbayashi, Tomoyuki Nakamura, Eri Muso, Takeshi Kimura, and Motoko Yanagita.
“Exploring the origin and limitations of kidney regeneration”
J Pathol. 2015;236(2):251–263. (Accepted: Feb 3, 2015)

2014年

(1)Shota Ozawa, Shuko Ueda, Ying Li, Kiyoshi Mori, Katsuhiko Asanuma, Motoko Yanagita, Takahiko Nakagawa.
“Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse”
Biochem Biophys Res Commun. 2014;454(4): 531–536. (Published: Oct 30,2014)

(2)Ayami Tsuchimoto, Haruka Shinke, Miwa Uesugi, Mio Kikuchi, Emina Hashimoto, Tomoko Sato, Yasuhiro
Ogura, Koichiro Hata, Yasuhiro Fujimoto, Toshimi Kaido, Junji Kishimoto, Motoko Yanagita, Kazuo Matsubara, Shinji Uemoto, Satohiro Masuda.
“Urinary neutrophil gelatinase-associated lipocalin: A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients”
PLoS One. 2014;9:e110527. (Accepted: Sep 23, 2014)

(9)Junya Kanda, Kiyoshi Mori, Hiroshi Kawabata, Takashige Kuwabara, Keita P. Mori, Hirotaka Imamaki, Masato Kasahara, Hideki Yokoi, Chisaki Mizumoto, Nils H. Thoennissen, H. Phillip Koeffler, Jonathan Barasch, Akifumi Takaori-Kondo, Masashi Mukoyama, Kazuwa Nakao.
“An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions”
Clin Exp Nephrol. 2015;19(1):99–106. (Accepted: Feb 17, 2014)

(4)Sachiko Yamada, Jin Nakamura, Misako Asada, Masayuki Takase, Taiji Matsusaka, Taku Iguchi, Ryo Yamada, Mari Tanaka, Atsuko Y Higashi, Tomohiko Okuda, Nariaki Asada,Atsushi Fukatsu, Hiroshi Kawachi, Daniel Graf, Eri Muso, Toru Kita, Takeshi Kimura, Ira Pastan, Aris N. Economides, and Motoko Yanagita.
“Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury”
PLoS One. 2014;9:e89135. (Accepted: Jan 20, 2014)

(6) Takeshige Kuwabara, Kiyoshi Mori, Masato Kasahara, Hideki Yokoi, Hirotaka Imamaki, Akira Ishii, Kenichi Koga, Akira Sugawara, Shinji Yasuno, Kenji Ueshima, Takashi Morikawa, Yoshio Konishi, Masahito Imanishi, Akira Nishiyama, Kazuwa Nakao, Masashi Mukoyama.
“Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases”
PLoS One. 2014; 9: e88942. (Accepted: Jan 14, 2014)

2013年

(8) Ryuichi Uetake, Takayuki Sakurai, Akiko Kamiyoshi, Yuka Ichikawa-Shindo, Hisaka Kawate, Yasuhiro Iesato, Takahiro Yoshizawa, Teruhide Koyama, Lei Yang, Yuichi Toriyama, Akihiro Yamauchi, Kyoko Igarashi, Megumu Tanaka, Takashige Kuwabara, Kiyoshi Mori, Motoko Yanagita, Masashi Mukoyama, Takayuki Shindo.
“Adrenomedullin-RAMP2 System Suppresses ER Stress-Induced Tubule Cell Death and Is Involved in Kidney”
PLoS One. 2014;9:e87667. (Accepted: Dec 29, 2013)

(7) Masato Kasahara, Takahiko Nakagawa, Hideki Yokoi, Takashige Kuwabara, Shinji Yasuno, Kiyoshi Mori, Masashi Mukoyama, Kenji Ueshima.
“Do statins play a role in renoprotection?”
Clin Exp Nephrol. 2014;18(2): 282–285. (Accepted: Dec 11, 2013)

(6) Takeshige Kuwabara, Kiyoshi Mori, Masashi Mukoyama, Masato Kasahara, Hideki Yokoi, and Kazuwa Nakao.
“Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy”
Clin Exp Nephrol. 2014;18(4):584–592. (Accepted: Nov 28, 2013)

(5) Koji Takaori, Motoko Yanagita.
“Kidney regeneration and stem cells”
Anat Rec (Hoboken). 2014; 297: 129–136. (Accepted: Sep 13, 2013)

(4) Yuichirou Kitai, Neiko Ozasa, Takeshi Morimoto, Bingyuan Bao, Yutaka Furukawa,
Yoshihisa Nakagawa, Kazushige Kadota, Motoko Yanagita, Satoshi Shizuta, Takeshi Kimura.
“Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention”
Int J Cardiol. 2013;168(6): 5221–5228. (Accepted: Aug 3, 2013)

(3) Mayumi Tomita, Misako Asada, Nariaki Asada, Jin Nakamura, Akiko Oguchi, Atsuko Y Higashi, Shuichiro Endo, Elizabeth Robertson, Takeshi Kimura, Toru Kita, Aris N. Economides, Jordan Kreidberg, Motoko Yanagita.
“Bmp7 maintains undifferentiated kidney progenitor population and determines nephron numbers at birth”
PLoS One.2013;8:e73554. (Accepted: Jul 29, 2013)

(2) Sato Y, Yanagita M.
“Renal anemia: from incurable to curable”
Am J Physiol Renal Physiol. 2013;305(9):F1239–F1248. (Accepted: Jul 19, 2013)

(1) Kenta Iijima, Noriyuki Okudaira, Masato Tamura, Akihiro Doi, Yoshikazu Saito, Mari Shimura, Motohito Goto, Akihiro Matsunaga, Yuki I Kawamura, Takeshi Otsubo, Taeko Dohi, Shigeki Hoshino, Shigeyuki Kano, Shotaro Hagiwara, Junko Tanuma, Hiroyuki Gatanaga, Masanori Baba, Taku Iguchi, Motoko Yanagita, Shinichi Oka, Tadashi Okamura, Yukihito Ishizaka.
“Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1”
Retrovirology. 2013;10:83. (Accepted: Jul 18, 2013)

2012年

(5) Yuki Nakanishi, Hiroshi Seno, Ayumi Fukuoka, Taro Ueo, Yuichi Yamaga, Takahisa Maruno, Naoko Nakanishi, Keitaro Kanda, Hideyuki Komekado, Mayumi Kawada, Akihiro Isomura, Kenji Kawada, Yoshiharu Sakai, Motoko Yanagita, Ryoichiro Kageyama, Yoshiya Kawaguchi, Makoto M Taketo, Shin Yonehara, Tsutomu Chiba.
“Dclk1 distinguishes between tumor and normal stem cells in the intestine”
Nat Genet. 2013;45(1):98–103. (Accepted: Nov 5, 2012)

(4) Kentaro Suzuki, Yasuha Adachi, Tomokazu Numata, Shoko Nakada, Motoko Yanagita, Naomi Nakagata, Sylvia M. Evans, Daniel Graf, Aris Economides, Ryuma Haraguchi, Anne M. Moon, Gen Yamada.
“Reduced BMP signaling results in hindlimb fusion with lethal pelvic/urogenitalorgan aplasia: a new mouse model of sirenomelia”
Plos One. 2012;7(9):e43453. (Accepted: Jul 24, 2012)

(3) Motoko Yanagita.
“Inhibitors/antagonists of the TGF-β system in kidney fibrosis”
Nephrol Dial Transplant. 2012;27(10):3686–3691. (Accepted: Jul 12, 2012)

(2) Hitomi Miyata, Kazuko Uno, Takahiko Ono, Masatomo Yashiro, Atsushi Fukatsu, Toru Kita, Takeshi Kimura, Eri Muso.
“Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome”
Ther Aper Dial. 2012;16(2): 189-194. (Published: Feb 27, 2012)

(1) Jin Nakamura, Motoko Yanagita.
“Bmp modulators in kidney disease”
Discov Med. 2012;13(68): 57-63. (Published: Jan 24, 2012)

2011年

(2) Nariaki Asada, Masayuki Takase, Jin Nakamura, Akiko Oguchi, Misako Asada, Norio Suzuki, Ken-ichi Yamamura, Narihito Nagoshi, Shinsuke Shibata, Tata Nageswara Rao, Hans Joerg Fehling, Atsushi Fukatsu, Naoko Minegishi, Toru Kita, Takeshi Kimura, Hideyuki Okano, Masayuki Yamamoto, Motoko Yanagita.
“Dysfunction of fibroblasts of extra-renal origin underlies renal fibrosis and renal anemia in mice”
J Clin Invest. 2011;121(10): 3981–3990. (Accepted: Jul 26, 2011)

(1) Hiroshi Kanamori, Kojiro Nagai, Takeshi Matsubara, Akira Mima, Motoko Yanagita, Noriyuki Iehara, Hajime Takechi, Keiichi Fujimaki, Kazumasa Usami, Atsushi Fukatsu, Toru Kita, Kozo Matsubayashi, Hidenori Arai.
“Comparison of the psychosocial quality of life in hemodialysis patients between the elderly and non-elderly using a visual analogue scale: the importance
of appetite and depressive mood”
Geriatr Gerontol Int. 2012;12(1):65–71. (Accepted: Jun 21, 2011)

2010年

(1) Motoko Yanagita.
“Antagonists of bone morphogenetic proteins in kidney disease”
Curr Opin Invest Drugs. 2010;11(3):315–322.

2009年

(3) Mari Tanaka, Misako Asada, Atsuko Y. Higashi, Jin Nakamura, Akiko Oguchi, Mayumi Tomita, Sachiko Yamada, Nariaki Asada, Masayuki Takase, Tomohiko Okuda, Hiroshi Kawachi, Aris N. Economides, Elizabeth Robertson, Satoru Takahashi, Takeshi Sakurai, Roel Goldschmeding, Eri Muso, Atsushi Fukatsu, Toru Kita, Motoko Yanagita.
“Loss of the BMP antagonist, USAG-1 ameliorates disease in a mouse model of progressive hereditary kidney disease Alport syndrome”
J Clin Invest. 2010;120(3):768–777. (Accepted: Nov 24, 2009)

(2) Kentaro Suzuki, Aris Economides, Motoko Yanagita, Daniel Graf, Gen Yamada.
“New horizons at the caudal embryos: coordinated urogenital/reproductive organ formation by growth factor signaling”
Curr Opin Genet Dev. 2009;19(5):491–496. (Published: Sep 16, 2009)

(1) Atsuko Yoshioka Higashi, Tomokatsu Ikawa, Masamichi Muramatsu, Aris N. Economides, Akira Niwa, Tomohiko Okuda, Andrew J. Murphy, Jose Rojas, Toshio Heike, Tatsutoshi Nakahata, Hiroshi Kawamoto, Toru Kita, Motoko Yanagita.
Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
J Immunol. 2009;182(9):5633–5640. (Accepted: Feb 26, 2009)

2008年

(3)Motoko Yanagita.
“BMP modulators regulate the function of BMP during body patterning and disease progression”
Biofactors. 2009;35(2):113–119. (Accepted: Nov 29. 2008)

2007年

(1)Mari Tanaka, Shuichiro Endo, Tomohiko Okuda, Aris N. Economides, David M. Valenzuela, Andrew J. Murphy, Elizabeth Robertson, Takeshi Sakurai, Atsushi Fukatsu, George D. Yancopoulos, Toru Kita, Motoko Yanagita.
“Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury”
Kidney Int. 2008;73(2):181–191. (Accepted: Aug 14, 2007)

2006年

(1) Motoko Yanagita.
“Modulator of bone morphogenetic protein activity in the progression of kidney diseases”
Kidney Int. 2006;70(6):989–993. (Accepted: Jun 2, 2006)

2005年

(2) Motoko Yanagita, Tomohiko Okuda, Shuichiro Endo, Mari Tanaka, Katsu Takahashi, Fumihiro Sugiyama, Satoshi Kunita, Satoru Takahashi, Atsushi Fukatsu, Masashi Yanagisawa, Toru Kita, Takeshi Sakurai.
“Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury”
J Clin Invest. 2006;116(1):70–79. (Accepted: Oct 11, 2005)

(1) Motoko Yanagita.
“BMP antagonists: their roles in development and involvement in pathophysiology”
Cytokine Growth Factor Rev. 2005;16(3):309–317. (Published: Jun 13, 2005)

2004年

(2) Motoko Yanagita.
“The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology”
Curr Opin Nephrol Hypertens. 2004;13(4):465–470. (Published: Jul 1, 2004)

(1) Motoko Yanagita, Masako Oka, Tetsuro Watabe, Haruhisa Iguchi, Atsushi Niida, Satoru Takahashi, Tetsu Akiyama, Kohei Miyazono, Masashi Yanagisawa, TakeshiSakura.
“USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney”
Biochem Biophys Res Commun. 2004;316(2):490–500. (Published: Feb 26, 2004)

発表論文(和文)

2019年

2018年

(1) 【大野 絵里菜, 遠藤 修一郎, 佐藤 憲明, 高橋 昌宏, 松原 雄, 横井 秀基, 柳田 素子】
「ステロイド不応性の蛋白尿を伴う進行性腎機能障害の1例」
臨牀透析 34巻10号 Page 1258-1265 (2018.09)

(2) 【佐藤 有紀, 柳田 素子】
「男性ホルモンと腎臓病」
腎臓内科・泌尿器科 8巻2号 Page 145-149 (2018.08)

(3) 【松原 雄, 柳田 素子】
「坑がん薬と急性腎障害(特集 腎疾患領域における薬剤管理 今注目されるポイント)」
日本内科学会雑誌107巻5号 Page 865-871 (2018.05)

(4) 【森 慶太, 柳田 素子】
「腎臓の線維化,腎性貧血のメカニズムとSGLT2阻害薬」
内分泌・糖尿病・代謝内科46巻4号 Page 305-309 (2018.04)

(5) 【好川 貴久, 佐藤 有紀, 柳田 素子】
「腎線維化を担う細胞とその多彩な機能(特集 線維化と腎泌尿器疾患)」
腎臓内科・泌尿器科7巻4号 Page 335-340 (2018.04)

(6) 【高折 光司, 柳田 素子】
「AKIとCKDのクロストーク」
日本透析医学会雑誌51巻2号 Page 159-165 (2018.02)

(7) 【森 潔, 森 慶太, 柳田 素子】
「AKIバイオマーカーの出現機序(特集 急性腎障害(AKI)の最新知見を凝縮する)」
腎・高血圧の最新治療 7巻1号 Page17-24 (2018.01)

(8) 【森 慶太, 森 潔】
「新視点 : 腎臓の濾過・再吸収からみた糖尿病性腎症におけるアルブミン尿」(TOPICS 腎臓内科学)
医学のあゆみ 264巻3号 Page 255-256 (2018.01)

(9) 【佐藤 有紀】
「虚血性AKIについて」
腎・高血圧の最新治療 7巻1号 Page 30-35 (2018.01)

(10) 【小口 亜希子, 佐藤 有紀, 柳田 素子】
「腎線維化の機序と治療」
Pharma Medica 36巻1号 Page 41-44 (2018.01)

2017年

(1) 【松原 雄, 柳田 素子】
「悪性腫瘍(特集 腎不全合併症治療のupdate)」
腎臓内科・泌尿器科5巻4号 Page349-355(2017.11)

(2) 【松原 雄, 柳田 素子】
「末期腎不全患者におけるがん診察の実態(特集 Onco-Nephrology(癌と腎臓病))」
医学のあゆみ262巻11号 Page1027-1031(2017.09)

(3) 【佐藤 有紀, 柳田 素子】
「高齢者のAKIはなぜ治りにくいのか?」
腎と透析 増大号 83巻3号 Page499-502(2017.09)

(4) 【松原 雄, 柳田 素子】
「Overview(特集 Onco-nephrology)」
日本腎臓学会誌59巻5号 Page590-593(2017.07)

(5) 【佐藤 有紀】
「加齢個体における腎三次リンパ組織形成メカニズムの解明」
アンチ・エイジング医学 13巻3号 Page366-371(2017.06)

(6) 【北井 悠一朗, 柳田 素子】
「性ホルモンと腎臓病(特集 腎泌尿器の女性・新生児医学)?(妊娠と腎泌尿器疾患)」
腎臓内科・泌尿器科5巻4号 Page349-355(2017.04)

(7) 【石井 輝, 横井 秀基, 森 潔, 森 慶太, 古賀 健一, 柳田 素子】
「糖尿病腎症は糸球体or尿細管障害のどちらから始まるか?(特集 糖尿病患者の腎機能障害)」
内分泌・糖尿病・代謝内科44巻3号 Page215-221(2017.03)

(8) 【柳田 素子, 前田 健一郎】
「編集長VISITING(400)学術的新領域Onco-nephrology診療・研究面で薬剤師とも連携」
医薬ジャーナル53巻3号 Page164-168(2017.03)

(9) 【姜 伶奈, 佐藤 有紀, 柳田 素子】
「性差と腎臓病」
腎臓 39巻(通巻114号) Page10-14(2017.03)

(10) 【石原 仁毅, 福間 真悟, 柳田 素子】
「Mendelian readomization」
腎臓内科・泌尿器科5巻1号 Page77-81(2017.01)

(11) 【近藤 尚哉, 武藤 学, 福原 俊一, 柳田 素子】
「慢性透析患者におけるがん薬物療法の実態」
日本透析医学会雑誌50巻1号 Page64-65(2017.01)

2016年

(1)【山本 恵則, 佐藤 有紀, 柳田 素子】
「最新のCKDのバイオマーカー(特集 慢性腎臓病(CKD)治療の最前線:生活習慣病への新たなアプローチ)–(CKD診断・治療のUp-to-Date)」
最新醫學71巻12号 Page2467-2472(2016.12)

(2)【松原 雄, 柳田 素子】
「抗がん薬と急性腎障害(特集 Onco-nephrology:腫瘍学と腎臓病学の融合)」
医薬ジャーナル52巻9号 Page69-74(2016.09)

(3)【北井 悠一朗, 柳田 素子】
「Onco-nephrologyとは(特集 Onco-nephrology:腫瘍学と腎臓病学の融合)」
医薬ジャーナル52巻9号
Page69-74(2016.09)

(4)【近藤 麻紀子, 柳田 素子】
「CKDの発症と進展(特集 急性腎障害(AKI)と慢性腎臓病(CKD))–(CKD)」
臨牀と研究93巻7号 Page934-937(2016.07)

(5)【姜 伶奈, 柳田 素子】
「慢性腎臓病における性差(特集Men’s Health)」
日本医師会雑誌145巻2号 Page1243-246(2016.05)

2015年

(1)【佐藤 有紀, 柳田 素子】
「腎臓における炎症と線維化 」
細胞 47巻4号 Page168-171(2015.04)

(2)【比良野 圭太, 柳田 素子】
「主要な疾患と先制医療 遺伝素因、環境因子、発症前診断の可能性、予防法代謝・内分泌疾患 腎疾患」
実験医学 (0288-5514)33巻7号 Page1071-1077(2015.05)

(3)【松原 雄, 比良野 圭太, 柳田 素子】
「Onco-Nephrology なぜいま注目を集めているのか」
臨床泌尿器科 (0385-2393)69巻7号 Page534-539(2015.06)

(4)【山田 博之, 塚本 達雄, 柳田 素子】
「ハイリスク・特殊血液浄化 overview」
腎臓内科・泌尿器科 (2188-9147)1巻6号 Page523-527(2015.06)

(5)【横井 秀基, 柳田 素子】
「トランスレーショナルリサーチへの誘い(第1回) トランスレーショナルリサーチとは何か?」
尿酸と血糖 (2188-952X)1巻2号 Page80-82(2015.07)

(6)【北井 悠一朗, 柳田 素子】
「テストステロンとアンチエイジング テストステロンと腎機能」
腎臓内科・泌尿器科 (2188-9147)2巻1号 Page45-49(2015.07)

(7)【塚本 達雄,
山田 敦美, 飯田 恵, 安馬 雅範, 柳田 素子】
「血液浄化器取り違え事故3年後における再発防止策進行状況と問題点」
日本急性血液浄化学会雑誌 (2185-1085)6巻1号 Page3-9(2015.06)

(8)【金子 惠一, 柳田 素子】
「トピックス 貧血治療の新しい流れ EPO産生細胞の機能回復を目指した治療」
腎と透析 (0385-2156)79巻1号 Page128-133(2015.07)

(9)【山本 伸也, 柳田 素子】
「腎臓におけるエネルギー産生と消費」
腎臓内科・泌尿器科 (2188-9147)2巻2号 Page217-225(2015.08)

(10)【森 潔,
土田 潤一, 桑原 孝成, 向山 政志, 横井 秀基, 笠原 正登, 柳田 素子】
「循環器疾患における各種バイオマーカーの意義 TLR4と関連因子」
Heart View (1342-6591)19巻12号 Page168-171(2015.11)

(11)【小口 綾貴子, 横井 秀基, 今牧 博貴, 桑原 孝成, 清水 葉子,
笠原 正登, 向山 政志, 塚本 達雄, 柳田 素子】
「腹膜透析中に急激に心嚢水・胸水を発症し、血液透析移行後著明に改善した心外膜炎の1例」
腎と透析 (0385-2156)79巻別冊 腹膜透析2015 Page165-166(2015.10)

(12)【佐藤 有紀, 柳田 素子】
「腎線維化の原因細胞と成因」
日本腎臓学会誌
(0385-2385)57巻7号 Page1187-1192(2015.10)

(13)【高折 光司, 柳田 素子】
「腎臓病治療の将来:basic scienceからonconephrologyまで」
麻酔64(増刊)PageS1-9(2015.11)

(14)【山田 博之,
塚本 達雄, 宮田 仁美, 秦 浩一郎, 岡島 英明, 上本 伸二, 柳田 素子】
「消化器肝臓疾患とアフェレシス療法 劇症肝炎、肝移植へのアフェレシス療法」
腎と透析 (0385-2156)78巻2号 Page218-221(2015.02)

(15)【森 潔, 横井 秀基, 笠原 正登, 向山 政志, 柳田 素子】
「ポドサイトに発現する受容体」
腎と透析 (0385-2156)78巻3号 Page373-379(2015.03)

(16)【比良野 圭太, 柳田 素子】特集Onconephrology-腎臓病とがんの深いかかわり-
「なぜ今Onconephrologyが必要か:現状と今後の展開」
腎臓内科・泌尿器科 1巻1号
1-9, 科学評論社 2015.

(17)【松原 雄】特集Onconephrology-腎臓病とがんの深いかかわり-
「腎不全患者のがん治療 2)腎不全患者におけるがん診療の病態」
腎臓内科・泌尿器科 1巻1号
61-67, 科学評論社 2015.

2014年

(1)【中田 紘介, 柳田 素子】
「腎疾患とEPO産生細胞」
日本内科学会雑誌 103(1) 160-165 2014

(2)【森 潔, 桑原 孝成, 横井 秀基, 笠原 正登, 向山 政志, 柳田 素子】
「急性腎障害のバイオマーカー動向」
臨床化学
43(1) 5-8 2014

(3)【金子 惠一, 柳田 素子】
「腎間質細胞とCKD」
Medical Science Digest 40(4) 162-165 2014

(4)【佐藤 有紀, 柳田 素子】
「腎性貧血と腎機能低下はどこまで治るのか」
腎と透析 76巻2号(2月号) 252-255, 東京医学社 2014.

(5)【佐藤 有紀, 柳田 素子】
「胎内環境と慢性疾患」
Medicina 51(10) 1984-1986, 2014.

(6)【佐藤 有紀, 柳田 素子】
「線維化と腎性貧血を繋ぐ病態の解明」
全人力・科学力・透析力に基づく透析医学 第6章 351-354 医薬ジャーナル社 2014.

(7)【佐藤 有紀, 柳田 素子】
「研究施設紹介:京都大学大学院医学研究科腎臓内科学講座」
Nephrology Frontier 13 (1) 92-95, 2014.

(8)【山本 伸也,
柳田 素子】
「Bardoxolone methylに学ぶCKDの可逆性」
医学のあゆみ, 249(7), 627-629, 2014.

(9)【佐藤 有紀, 柳田 素子】
「腎線維化の機序と併存する病態との関連」
医学のあゆみ, 249(9), 953-958, 2014.

(10)【植村 忠廣,
山田 博之, 宮田 仁美, 塚本 達雄, 柳田 素子, 冨山 浩司, 岡島 英明, 海道 利実, 上本 伸二】
「肝移植におけるICU管理」
ICUとCCU 38(2): 91-95, 2014.

(11)【森 慶太, 笠原 正登】
「hANP(カルペリチド)」
循環器内科第75(3): 280-287 2014.

2013年

(1)【松原 雄, 柳田 素子】
「腎疾患に対する薬剤の使用方法 虚血性腎症」
腎と透析 74巻増刊 254-256 2013

(2)【塚本 達雄】
「透析患者に対する薬の使い方 対症療法 女性化乳房」
腎と透析 74巻増刊 427-430 2013

(3)【塚本 達雄, 柳田 素子】
「持続血液浄化療法施行中の医療器具取り違えによる肝移植後患者死亡-事例報告と再発防止策-」
日本急性血液浄化学会雑誌 4(2) 148-153 2013

(4)【佐藤 有紀, 柳田 素子】
「CKDにおける貧血と臓器保護」
腎と透析9月号, 319-322, 東京医学 2013

(5)【中村 仁, 柳田 素子】
「腎線維化のメカニズム」
Annual Review 腎臓2013, 75-79, 中外医学社 2013

(6)【佐藤 有紀, 柳田 素子】
「慢性腎臓病と慢性炎症」
慢性炎症と生活習慣病 第II部, 91-100, 南山堂 2013

(7)【佐藤 有紀, 柳田 素子】
「腎線維化」
Current Therapy 2013, 31(6), p8-12 ライフメディコム

2012年

(1)【柳田 素子】
「尿細管性アシドーシスとその他の尿細管疾患」
今日の治療指針2012 医学書院 2012

(2)【高折 光司, 柳田 素子】
「基礎研究の治験を腎臓病診療に生かす」
Medicina 49(5), 904-906, 2012

(3)【佐藤 有紀, 柳田 素子】
「Alport症候群」
臨床雑誌 内科 109(6),1366-1367, 南江堂 2012

(4)【高瀬 昌幸, 柳田 素子】
「線維化と腎性貧血を制御する」
細胞 44(5), 208-211, 2012

(5)【高折 光司, 柳田 素子】
「腎線維化の病態解明と治療戦略」
医薬ジャーナル 48(11), 2571-2574, 2012

(6)【高折 光司, 柳田 素子】
「糖尿病性腎症の治療戦略」
BIO Clinica, 27(14),
1322-1326, 2012

2011年

(1)【松原 雄, 家原 典之, 深津 敦司】電解質異常(低カリウム血症, 高カルシウム血症)(特集 腎障害をきたす全身性疾患‐最近の進歩)
日本内科学会雑誌, 100(5), 1313-1318, 2011

(2)【長尾 和浩, 西岡 敬祐, 前田 利彦, 田中 麻理, 遠藤 修一郎,
宮田 仁美, 松原 雄, 家原 典之, 深津 敦司】不明熱の原因としてgraft intolerance syndrome(GIS)が強く疑われた移植腎機能廃絶後の腹膜透析患者の一例
腎と透析 71巻別冊 腹膜透析, P125-126, 2011

(3)【高折 光司, 柳田 素子】
「USAG-1, BMPアンタゴニストと腎疾患」
感染・炎症・免疫, 41(3), 239-241, 2011

(4)【佐藤 有紀, 柳田 素子】
「慢性腎臓病における糸球体・尿細管クロストーク」
BIO Clinica, 27(1), 95-99, 2011

(5)【高瀬 昌幸, 柳田 素子】
「線維化を起こす細胞群と腎性貧血」
医学のあゆみ, 240(4), 288-292, 2011

Book Chapter

1 Takeshi Yokoo and Motoko Yanagita.
“Stem cell therapy against oxidative stress and hypoxia.”(Book chapter)
“Oxidative Stress and Hypoxia in Renal Disorders”,
edited by Kai-Uwe
Eckardt and Toshio Miyata, published from The Human Press/Springer Science, 2011.

2 Motoko Yanagita
“BMP antagonists and kidney.” (Book chapter)
“Bone Morphogenetic Protein:
From Local to Systemic Therapeutics”,
edited by Vukicevic Slobodan and Kuber Sampath, published from Birkhauser, Springer Verlag, 2008.

3 Motoko Yanagita
“Uterine Sensitization
Associated Gene-1 (USAG-1): A Bone Morphogenetic Protein Antagonist in the Kidney.” (Book chapter)
“TRANSFORMING GROWTH FACTOR-β IN CANCER THERAPY”,
edited by Sonia B. Jakowlew, published from